IRCT20161010030246N5招募中3 期
Evaluating the effectiveness of pentoxifylline on the prevention of gentamicin nephrotoxicity in hospitalized patients in Shiraz
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit(—)
- 性别
- All
入选标准
- •Age higher than 18 years
- •Receiving intravenous or intramuscular gentamicin for at least 1 week
- •No confirmed acute or chronic kidney injury
- •Do not take gentamicin intravenously or intramuscularly during the past 14 days
- •Do not take pentoxifylline orally during the past week
- •No confirmed history of allergic reactions to pentoxifylline
- •Informed consent form
排除标准
- •Patient with hemodynamic instability
- •Concomitant use of medicines or antioxidant compounds such as vitamin C, vitamin E, or vitamin A
- •Concomitant use of medications with high renal toxicity
- •No tolerant of oral medications
研究者
相似试验
已完成
2 期
The evaluation of the effect of pentoxifylline on diabetic foot ulcersIRCT20180818040823N1Tehran University of Medical Sciences18
尚未招募
2 期
The effect of Pentoxifylline for the treatment of major depression in cardiovascular patientsIRCT20090117001556N132Tehran University of Medical Sciences50
尚未招募
3 期
Evaluation of the effect of pentoxifylline on the prevention of erythrocyte lysis in cardiac surgery patientsAll patients undergo open heart surgery.IRCT20210420051018N1Semnan University of Medical Sciences15
已完成
2 期
Effect of pentoxifillyn on COVID-19IRCT20210517051326N1Shahid Beheshti University of Medical Sciences70
已完成
3 期
Investigation of the effect of pentoxifylline on the prevention of radio contrast nephropathyIRCT20161219031464N4Shahid Beheshti University of Medical Sciences192
